{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:14:21Z","timestamp":1793297661395,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Innovation Research Fund for Jiangning Hospital Affiliated to Nanjing Medical University"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402052"],"award-info":[{"award-number":["82402052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231146"],"award-info":[{"award-number":["BK20231146"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the General Program of Wuxi Medical Center, Nanjing Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gastric cancer (GC) is a common and aggressive malignancy worldwide. Increasing evidence has shown that epigenetic changes are closely related to the development of cancer and tumor-associated macrophages. Here, we report that PRMT1 is a key immunosuppressive factor in GC. PRMT1 is upregulated in GC and promotes tumor progression. PRMT1 knockdown in GC leads to the activation of the cGAS\/STING pathway through the enhancement of dsDNA aggregation, which subsequently increases IFN-\u03b2 secretion. Notably, after PRMT1 knockdown, M1-like tumor-associated macrophage (TAM) infiltration increased, whereas M2-like TAM infiltration decreased in vivo and in vitro. After the targeted inhibition of STING by siRNA or H151, the improvement in the progression of GC caused by PRMT1 knockdown decreased, and the changes in macrophage polarization were reversed. Furthermore, we found that PRMT1 knockdown in GC affects the STAT pathway in TAMs, inducing changes in their polarization and promoting GC apoptosis by enhancing IFN-\u03b2 secretion through the cGAS\/STING pathway. In summary, our findings revealed that PRMT1 knockdown inhibits the cGAS\/STING pathway in GC, which produces type I IFNs to promote the polarization of M1-like macrophages in the tumor microenvironment.<\/jats:p>","DOI":"10.1038\/s41419-025-07960-y","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:52:15Z","timestamp":1756223535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Tumor-derived PRMT1 suppresses macrophage antitumor activity by inhibiting cGAS\/STING signaling in gastric cancer cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiweng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2580-1085","authenticated-orcid":false,"given":"Qibin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-5475","authenticated-orcid":false,"given":"Qiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"7960_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA: Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA: Cancer J Clin"},{"key":"7960_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet (Lond, Engl). 2020;396:635\u201348.","journal-title":"Lancet (Lond, Engl)"},{"key":"7960_CR3","first-page":"534","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clinical Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2020;18:534\u201342.","journal-title":"Clinical Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"7960_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","volume":"70","author":"M Zhang","year":"2021","unstructured":"Zhang M, Hu S, Min M, Ni Y, Lu Z, Sun X, et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut. 2021;70:464\u201375.","journal-title":"Gut"},{"key":"7960_CR5","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.abb4255","volume":"369","author":"EN Chin","year":"2020","unstructured":"Chin EN, Yu C, Vartabedian VF, Jia Y, Kumar M, Gamo AM, et al. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science (N. Y, NY). 2020;369:993\u20139.","journal-title":"Science (N. Y, NY)"},{"key":"7960_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","volume":"53","author":"JW Hwang","year":"2021","unstructured":"Hwang JW, Cho Y, Bae GU, Kim SN, Kim YK. Protein arginine methyltransferases: promising targets for cancer therapy. Experimental Mol Med. 2021;53:788\u2013808.","journal-title":"Experimental Mol Med"},{"key":"7960_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ccell.2015.12.007","volume":"29","author":"N Cheung","year":"2016","unstructured":"Cheung N, Fung TK, Zeisig BB, Holmes K, Rane JK, Mowen KA, et al. Targeting aberrant epigenetic networks mediated by prmt1 and kdm4c in acute myeloid leukemia. Cancer cell. 2016;29:32\u201348.","journal-title":"Cancer cell"},{"key":"7960_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ijc.25366","volume":"128","author":"M Yoshimatsu","year":"2011","unstructured":"Yoshimatsu M, Toyokawa G, Hayami S, Unoki M, Tsunoda T, Field HI, et al. Dysregulation of PRMT1 and PRMT6, type I arginine methyltransferases, is involved in various types of human cancers. International J cancer. 2011;128:562\u201373.","journal-title":"International J cancer"},{"key":"7960_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.molmed.2019.05.007","volume":"25","author":"J Jarrold","year":"2019","unstructured":"Jarrold J, Davies CC. PRMTs and arginine methylation: cancer\u2019s best-kept secret?Trends Mol Med. 2019;25:993\u20131009.","journal-title":"Trends Mol Med"},{"key":"7960_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01009-1","volume":"8","author":"S Infantino","year":"2017","unstructured":"Infantino S, Light A, O\u2019Donnell K, Bryant V, Avery DT, Elliott M, et al. Arginine methylation catalyzed by PRMT1 is required for B cell activation and differentiation. Nat Commun. 2017;8:891.","journal-title":"Nat Commun"},{"key":"7960_CR11","doi-asserted-by":"crossref","unstructured":"Sung BY, Lin YH, Kong Q, Shah PD, Glick Bieler J, Palmer S, et al. Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1. J Clin Invest. 2022;132:e140508.","DOI":"10.1172\/JCI140508"},{"key":"7960_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217354","volume":"610","author":"K Yoshimura","year":"2025","unstructured":"Yoshimura K, Zou G, Fan Y, Yamashita K, Wang L, Wu J, et al. HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Lett. 2025;610:217354.","journal-title":"Cancer Lett"},{"key":"7960_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-associated macrophages in tumor immunity. Front Immunol. 2020;11:583084.","journal-title":"Front Immunol"},{"key":"7960_CR14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science (N. Y, NY). 2013;339:786\u201391.","journal-title":"Science (N. Y, NY)"},{"key":"7960_CR15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature08476","volume":"461","author":"H Ishikawa","year":"2009","unstructured":"Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461:788\u201392.","journal-title":"Nature"},{"key":"7960_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018;15:325\u201340.","journal-title":"Nat Rev Clin Oncol"},{"key":"7960_CR17","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.7150\/ijbs.80323","volume":"19","author":"S Ye","year":"2023","unstructured":"Ye S, Tian X, Anwaier A, Wei S, Liu W, Su J, et al. Protein arginine methyltransferases refine the classification of clear cell renal cell carcinoma with distinct prognosis and tumor microenvironment characteristics. Int J Biol Sci. 2023;19:4552\u201370.","journal-title":"Int J Biol Sci"},{"key":"7960_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216568","volume":"582","author":"L Ding","year":"2024","unstructured":"Ding L, Qian J, Yu X, Wu Q, Mao J, Liu X, et al. Blocking MARCO(+) tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway. Cancer Lett. 2024;582:216568.","journal-title":"Cancer Lett"},{"key":"7960_CR19","first-page":"149","volume":"7","author":"M Pelleitier","year":"1975","unstructured":"Pelleitier M, Montplaisir S. The nude mouse: a model of deficient T-cell function. Methods Achiev Exp Pathol. 1975;7:149\u201366.","journal-title":"Methods Achiev Exp Pathol"},{"key":"7960_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","volume":"20","author":"Q Wu","year":"2021","unstructured":"Wu Q, Schapira M, Arrowsmith CH, Barsyte-Lovejoy D. Protein arginine methylation: from enigmatic functions to therapeutic targeting. Nature Rev Drug Discov. 2021;20:509\u201330.","journal-title":"Nature Rev Drug Discov"},{"key":"7960_CR21","doi-asserted-by":"crossref","unstructured":"Suresh S, Huard S, Brisson A, N\u00e9mati F, Dakroub R, Poulard C, et al. PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancer. Cancers. 2022;14:306.","DOI":"10.3390\/cancers14020306"},{"key":"7960_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41419-024-06544-6","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu H, Chen X, Wang P, Chen M, Deng C, Qian X, et al. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis. Cell Death Dis. 2024;15:170.","journal-title":"Cell Death Dis"},{"key":"7960_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36708-5","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Luo L, Fu S, Wang M, Wang Z, Dong L, et al. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. Nat Commun. 2023;14:1011.","journal-title":"Nat Commun"},{"key":"7960_CR24","first-page":"2219","volume":"18","author":"X Meng","year":"2019","unstructured":"Meng X, Zhao Y, Liu J, Wang L, Dong Z, Zhang T, et al. Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer. Exp Therap Med. 2019;18:2219\u201330.","journal-title":"Exp Therap Med"},{"key":"7960_CR25","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.gendis.2023.02.006","volume":"10","author":"F Wang","year":"2023","unstructured":"Wang F, Chen S, Peng S, Zhou X, Tang H, Liang H, et al. PRMT1 promotes the proliferation and metastasis of gastric cancer cells by recruiting MLXIP for the transcriptional activation of the \u03b2-catenin pathway. Genes Dis. 2023;10:2622\u201338.","journal-title":"Genes Dis"},{"key":"7960_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature12306","volume":"498","author":"A Ablasser","year":"2013","unstructured":"Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, R\u00f6hl I, et al. cGAS produces a 2\u2019-5\u2019-linked cyclic dinucleotide second messenger that activates STING. Nature. 2013;498:380\u20134.","journal-title":"Nature"},{"key":"7960_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","volume":"29","author":"L Schadt","year":"2019","unstructured":"Schadt L, Sparano C, Schweiger NA, Silina K, Cecconi V, Lucchiari G, et al. Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity. Cell Rep. 2019;29:1236\u201348.e7.","journal-title":"Cell Rep"},{"key":"7960_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41556-019-0352-z","volume":"21","author":"S Wu","year":"2019","unstructured":"Wu S, Zhang Q, Zhang F, Meng F, Liu S, Zhou R, et al. HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity. Nature cell Biol. 2019;21:1027\u201340.","journal-title":"Nature cell Biol"},{"key":"7960_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-021-02120-4","volume":"40","author":"C Li","year":"2021","unstructured":"Li C, Shen Q, Zhang P, Wang T, Liu W, Li R, et al. Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS\/STING signaling in gastric cancer cells. J Exp Clin cancer Res: Cr. 2021;40:315.","journal-title":"J Exp Clin cancer Res: Cr"},{"key":"7960_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s12964-024-01893-3","volume":"22","author":"KS Oh","year":"2024","unstructured":"Oh KS, Nam AR, Bang JH, Jeong Y, Choo SY, Kim HJ, et al. Immunomodulatory effects of trastuzumab deruxtecan through the cGAS-STING pathway in gastric cancer cells. Cell Commun Signal: Ccs. 2024;22:518.","journal-title":"Cell Commun Signal: Ccs"},{"key":"7960_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep39858","volume":"7","author":"S Song","year":"2017","unstructured":"Song S, Peng P, Tang Z, Zhao J, Wu W, Li H, et al. Decreased expression of STING predicts poor prognosis in patients with gastric cancer. Sci Rep. 2017;7:39858.","journal-title":"Sci Rep"},{"key":"7960_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/thno.37745","volume":"10","author":"L Miao","year":"2020","unstructured":"Miao L, Qi J, Zhao Q, Wu QN, Wei DL, Wei XL, et al. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells. Theranostics. 2020;10:498\u2013515.","journal-title":"Theranostics"},{"key":"7960_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add8928","volume":"8","author":"L Liu","year":"2022","unstructured":"Liu L, Lin B, Yin S, Ball LE, Delaney JR, Long DT, et al. Arginine methylation of BRD4 by PRMT2\/4 governs transcription and DNA repair. Science Adv. 2022;8:eadd8928.","journal-title":"Science Adv"},{"key":"7960_CR34","doi-asserted-by":"crossref","unstructured":"Kim H, Kim H, Feng Y, Li Y, Tamiya H, Tocci S, et al. PRMT5 control of cGAS\/STING and NLRC5 pathways defines melanoma response to antitumor immunity. Science translational medicine. Sci Transl Med. 2020;12:eaaz5683.","DOI":"10.1126\/scitranslmed.aaz5683"},{"key":"7960_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/0008-5472.CAN-23-1082","volume":"84","author":"H Tao","year":"2024","unstructured":"Tao H, Jin C, Zhou L, Deng Z, Li X, Dang W, et al. PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma. Cancer Res. 2024;84:419\u201333.","journal-title":"Cancer Res"},{"key":"7960_CR36","doi-asserted-by":"crossref","unstructured":"Lecoultre M, Dutoit V, Walker PR. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. J Immunother Cancer. 2020;8:e001408.","DOI":"10.1136\/jitc-2020-001408"},{"key":"7960_CR37","doi-asserted-by":"crossref","unstructured":"Sullivan KM, Li H, Yang A, Zhang Z, Munoz RR, Mahuron KM, et al. Tumor and peritoneum-associated macrophage gene signature as a novel molecular biomarker in gastric cancer. Int J Mol Sci. 2024;25:4117.","DOI":"10.3390\/ijms25074117"},{"key":"7960_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13046-017-0528-y","volume":"36","author":"P Zheng","year":"2017","unstructured":"Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie G, et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J Exp Clin Cancer Res. 2017;36:53.","journal-title":"J Exp Clin Cancer Res"},{"key":"7960_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03453-8","volume":"24","author":"P Su","year":"2024","unstructured":"Su P, Yu T, Zhang Y, Huang H, Chen M, Cao C, et al. Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1\/JAK2\/STAT3 pathway in gastric cancer. Cancer Cell Int. 2024;24:287.","journal-title":"Cancer Cell Int"},{"key":"7960_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","volume":"53","author":"X Zhang","year":"2020","unstructured":"Zhang X, Bai XC, Chen ZJ. Structures and mechanisms in the cGAS-STING innate immunity pathway. Immunity. 2020;53:43\u201353.","journal-title":"Immunity"},{"key":"7960_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33301-0","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Liu Y, Xue C, Hu Y, Zhao Y, Cai K, et al. A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses. Nat Commun. 2022;13:5685.","journal-title":"Nat Commun"},{"key":"7960_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.117284","volume":"287","author":"X Li","year":"2024","unstructured":"Li X, Huang Y, Zu D, Liu H, He H, Bao Q, et al. PMMA nanoplastics induce gastric epithelial cellular senescence and cGAS-STING-mediated inflammation via ROS overproduction and NHEJ suppression. Ecotoxicol Environ Saf. 2024;287:117284.","journal-title":"Ecotoxicol Environ Saf"},{"key":"7960_CR43","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel KB, Bozlar M, De Valk AF, Greten FR. Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin Cancer Res. 2023;29:1009\u201316.","journal-title":"Clin Cancer Res"},{"key":"7960_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-022-00591-0","volume":"19","author":"Y Zavros","year":"2022","unstructured":"Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:451\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7960_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","volume":"79","author":"R Yu","year":"2022","unstructured":"Yu R, Zhu B, Chen D. Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell Mol Life Sci. 2022;79:191.","journal-title":"Cell Mol Life Sci"},{"key":"7960_CR46","doi-asserted-by":"crossref","unstructured":"Medvedeva GF, Kuzmina DO, Nuzhina J, Shtil AA, Dukhinova MS. How macrophages become transcriptionally dysregulated: a hidden impact of antitumor therapy. Int J Mol Sci. 2021;22(5):2662.","DOI":"10.3390\/ijms22052662"},{"key":"7960_CR47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2016.10.013","volume":"25","author":"EPC van der Vorst","year":"2017","unstructured":"van der Vorst EPC, Theodorou K, Wu Y, Hoeksema MA, Goossens P, Bursill CA, et al. High-density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-\u03baB\/STAT1-IRF1 signaling. Cell Metab. 2017;25:197\u2013207.","journal-title":"Cell Metab"},{"key":"7960_CR48","doi-asserted-by":"publisher","first-page":"794","DOI":"10.4049\/jimmunol.159.2.794","volume":"159","author":"A Lehtonen","year":"1997","unstructured":"Lehtonen A, Matikainen S, Julkunen I. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol (Baltim, Md: 1950). 1997;159:794\u2013803.","journal-title":"J Immunol (Baltim, Md: 1950)"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07960-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:51:19Z","timestamp":1757443879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07960-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7960"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07960-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"649"}}